血漿分画製剤の世界市場：2033年までの機会と戦略

世界の血漿分画製剤市場は2018年に317億1,270万米ドルと評価され、CAGR8.0％以上で2023年まで成長しました。

血友病有病率の上昇

血友病有病率の上昇は、これまでの血漿分画製剤市場の成長を牽引しました。血友病は、血液が適切に凝固しないことを特徴とする遺伝性疾患です。この疾患は一般的に遺伝性で、主に男性が罹患します。血漿分画製剤は、止血を回復し、出血エピソードを効果的に予防または治療するために必要な凝固因子を提供することにより、血友病の管理において重要な役割を果たしています。遺伝子組換え血液凝固因子製剤は安全性と供給安定性が向上しているが、特に遺伝子組換え製剤の入手が困難な地域や遺伝子組換え製剤に対するインヒビターを有する患者にとっては、血漿由来因子が依然として重要です。血液媒介性病原体の伝播に関する懸念にもかかわらず、血漿由来製剤は血友病治療のための費用対効果が高く利用しやすい選択肢を提供し続け、出血エピソードの効果的な管理と止血の回復を保証しています。2022年8月、米国の国立公衆衛生機関である疾病対策予防センター（CDC）によると、米国人男性10万人あたり、血友病Bは3.7人、血友病Aは12人でした。さらに、米国では男性出生5,617人に1人、男性出生19,283人に1人が血友病Bに罹患しています。したがって、血友病有病率の上昇が血漿分画製剤市場を牽引しました。

目次

第1章 エグゼクティブサマリー

• 血漿分画製剤- 市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

• 一般的な市場の定義
• 概要
• 血漿分画製剤市場定義とセグメンテーション
• 市場セグメンテーション：タイプ別
  • アルブミン
  • 第VIII因子
  • 第IX因子
  • 免疫グロブリン
  • 高度免疫グロブリン
  • その他のタイプ
• 市場セグメンテーション：用途別
  • 血友病
  • 低ガンマグロブリン血症
  • 免疫不全疾患
  • フォン・ヴィレブランド病
  • その他のアプリケーション
• 市場セグメンテーション：エンドユーザー別
  • 病院
  • クリニック
  • その他のエンドユーザー

第7章 主要な市場動向

• サプライチェーンの回復力を強化するための新しい血漿製造施設
• 血漿生産能力の拡大に向けた投資増加
• B型肝炎ウイルスへの曝露に対処するための革新的な処方
• 血漿分画製剤開発を強化するための戦略的パートナーシップと協力

第8章 血漿分画製剤市場：マクロ経済シナリオ

• COVID-19の影響：血漿分画製剤市場
• ウクライナ戦争の影響：血漿分画製剤市場
• 高インフレの影響：血漿分画製剤市場

第9章 世界の市場規模と成長

• 市場規模
• 市場成長実績, 2018-2023
  • 市場促進要因2018-2023
  • 市場抑制要因2018-2023
• 市場成長予測, 2023-2028, 2033F
  • 市場促進要因2023-2028
  • 市場抑制要因2023-2028

第10章 世界の血漿分画製剤市場：セグメンテーション

• 世界の血漿分画製剤市場：タイプ別、実績と予測, 2018-2023, 2028F, 2033F
• 世界の血漿分画製剤市場：用途別、実績と予測, 2018-2023, 2028F, 2033F
• 世界の血漿分画製剤市場：エンドユーザー別、実績と予測, 2018-2023, 2028F, 2033F

第11章 血漿分画製剤市場：地域・国別分析

• 世界の血漿分画製剤市場：地域別、実績と予測, 2018-2023, 2028F, 2033F
• 世界の血漿分画製剤市場：国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

• 企業プロファイル
• CSL Limited
• China Biologic Products Holdings Inc.
• Takeda Pharmaceutical Company Limited
• Octapharma AG
• Bayer AG

第20章 その他の大手企業と革新的企業

• Kedrion S.p.A.
• Bio Products Ltd.
• Grifols S.A.
• LFB S.A.
• ADMA Biologics Inc.
• GC Biopharma Corp.
• Shanghai Raas Blood Products Co. Ltd.
• Emergent BioSolutions Inc.
• Biotest AG
• SK Plasma Co., Ltd.
• BioreclamationIVT
• Fusion Health Care Pvt. Ltd.
• PlasmaGen BioSciences Private Limited
• Cambryn Biologics LLC
• Sanquin Innovation B.V.

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主要な合併と買収

• Pfizer Inc. Acquired Blood Therapeutics Inc.
• Grifols S.A. Acquired Biotest AG
• Grifols S.A. Acquired 25 Plasma Centers From BPL Plasma Inc.
• Permira Acquired Kedrion Biopharma
• Kamada Ltd. Acquired FDA-Licensed Plasma Collection Center From Blood and Plasma Research Inc.

第24章 機会と戦略

• 世界の血漿分画製剤市場、2028年：新たな機会を提供する国
• 世界の血漿分画製剤市場、2028年：新たな機会を提供するセグメント
• 世界の血漿分画製剤市場、2028年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第25章 血漿分画製剤市場：結論と提言

• 結論
• 提言
  • 製品
  • 場所
  • 価格
  • プロモーション
  • 人々

第26章 付録

Blood plasma derivatives are medical products derived from human blood plasma. Plasma is the liquid component of blood that remains after cells (red blood cells, white blood cells and platelets) are removed. Plasma derivatives are typically obtained through a process called fractionation, where plasma proteins are separated and purified from the collected plasma.

The blood plasma derivatives market consists of sales, by entities (organizations, sole traders and partnerships), of products derived from the plasma portion of human blood.

The global blood plasma derivatives market was valued at $31,712.7 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 8.0%.

Rise In Hemophilia Prevalence

The rise in hemophilia prevalence drove the growth of the blood plasma derivatives market during this historic period. Hemophilia is a genetic disorder characterized by the inability of the blood to clot properly. This condition is typically inherited and primarily affects males. Blood plasma derivatives play a crucial role in the management of hemophilia by providing the necessary clotting factors to restore hemostasis and prevent or treat bleeding episodes effectively. While recombinant clotting factor products offer enhanced safety profiles and supply stability, plasma-derived factors remain crucial, especially in regions with limited access to recombinant products or for patients with inhibitors against them. Despite concerns regarding blood-borne pathogen transmission, plasma-derived products continue to provide a cost-effective and accessible option for treating hemophilia, ensuring the effective management of bleeding episodes and restoration of hemostasis. In August 2022, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, for every 100,000 American males, there were 3.7 instances of hemophilia B and 12 cases of hemophilia A, respectively. Moreover, it affects 1 in 5,617 male births in the US and 1 in 19,283 male births with hemophilia B. Therefore, the rise in hemophilia prevalence drove the blood plasma derivatives market.

Increasing Investments To Expand Blood Plasma Production Capabilities

Companies in the blood plasma derivatives market are focusing on increasing their investments to capitalize on growth opportunities and contribute to long-term sustainability and profitability. For example, in September 2022, Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company, invested close to $330 million in expanding its plasma-derived therapy production. This investment aims to enhance access to treatments for rare and complex chronic diseases, such as primary immunodeficiencies and rare conditions like hereditary angioedema and bleeding disorders. Furthermore, in March 2023, CSL Plasma, a US-based plasmapheresis company, invested $470 million to establish a new plasma fractionation facility at its site located in Marburg to expand its production capabilities and enhance its commitment to delivering on its promise to patients.

The global blood plasma derivatives market is fairly concentrated, with a large number of players operating in the market. The top ten competitors in the market made up to 22.6% of the total market in 2022.

Blood Plasma Derivatives Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global blood plasma derivatives market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for blood plasma derivatives? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The blood plasma derivatives market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider blood plasma derivatives market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by application and by end-user.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the blood plasma derivatives market.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations-This section includes recommendations for blood plasma derivatives providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Type: Albumin; Factor VIII; Factor IX; Immunoglobulin; Hyperimmune Globulin; Other Types
• 2) By Application: Haemophilia; Hypogammaglobulinemia; Immunodeficiency Diseases; Von Willebrand's Disease; Other Application
• 3) By End-User: Hospitals; Clinics; Other End-Users
• Companies Mentioned: CSL Limited; China Biologic Products Holdings Inc.; Takeda Pharmaceutical Company Limited; Octapharma AG; Bayer AG
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; blood plasma derivatives indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Blood Plasma Derivatives - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Blood Plasma Derivatives Market Definition And Segmentations
• 6.4 Market Segmentation By Type
  • 6.4.1 Albumin
  • 6.4.2 Factor VIII
  • 6.4.3 Factor IX
  • 6.4.4 Immunoglobulin
  • 6.4.5 Hyperimmune Globulin
  • 6.4.6 Other Types
• 6.5 Market Segmentation By Application
  • 6.5.1 Hemophilia
  • 6.5.2 Hypogammaglobulinemia
  • 6.5.3 Immunodeficiency Diseases
  • 6.5.4 Von Willebrand's Disease
  • 6.5.5 Other Applications
• 6.6 Market Segmentation By End-User
  • 6.6.1 Hospitals
  • 6.6.2 Clinics
  • 6.6.3 Other End-Users

7 Major Market Trends

• 7.1 New Blood Plasma Manufacturing Facilities To Enhance Supply Chain Resilience
• 7.2 Increasing Investments To Expand Blood Plasma Production Capabilities
• 7.3 Innovative Formulations To Address Hepatitis B Virus Exposure
• 7.4 Strategic Partnerships And Collaborations To Strengthen Blood Plasma Derivatives Development

8 Blood Plasma Derivatives Market - Macro Economic Scenario

• 8.1 COVID-19 Impact On The Blood Plasma Derivatives Market
• 8.2 Impact Of The War In Ukraine On The Blood Plasma Derivatives Market
• 8.3 Impact Of High Inflation On The Blood Plasma Derivatives Market

9 Global Market Size and Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global Blood Plasma Derivatives Market Segmentation

• 10.1 Global Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Blood Plasma Derivatives Market, Regional and Country Analysis

• 11.1 Global Blood Plasma Derivatives Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global Blood Plasma Derivatives Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
  • 12.1.1 Market Overview
  • 12.1.2 Region Information
  • 12.1.3 Market Information
  • 12.1.4 Background Information
  • 12.1.5 Government Initiatives
  • 12.1.6 Regulations
  • 12.1.7 Regulatory Bodies
  • 12.1.8 Major Associations
  • 12.1.9 Taxes Levied
  • 12.1.10 Corporate Tax Structure
  • 12.1.11 Investments
  • 12.1.12 Major Companies
• 12.2 Asia-Pacific Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.3 Asia-Pacific Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia-Pacific Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia-Pacific Blood Plasma Derivatives Market: Country Analysis
• 12.6 China Market
• 12.7 Summary
  • 12.7.1 Market Overview
  • 12.7.2 Country Information
  • 12.7.3 Market Information
  • 12.7.4 Background Information
  • 12.7.5 Government Initiatives
  • 12.7.6 Regulations
  • 12.7.7 Regulatory Bodies
  • 12.7.8 Major Associations
  • 12.7.9 Taxes Levied
  • 12.7.10 Corporate Tax Structure
  • 12.7.11 Investments
  • 12.7.12 Major Companies
• 12.8 China Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.9 China Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.10 China Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 India Market
• 12.12 India Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.14 India Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 Japan Market
• 12.16 Japan Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Japan Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.18 Japan Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Australia Market
• 12.20 Australia Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Australia Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.22 Australia Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Indonesia Market
• 12.24 Indonesia Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Indonesia Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.26 Indonesia Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 South Korea Market
• 12.28 South Korea Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.29 South Korea Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.30 South Korea Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
  • 13.1.1 Market Overview
  • 13.1.2 Region Information
  • 13.1.3 Market Information
  • 13.1.4 Background Information
  • 13.1.5 Government Initiatives
  • 13.1.6 Regulations
  • 13.1.7 Regulatory Bodies
  • 13.1.8 Major Associations
  • 13.1.9 Taxes Levied
  • 13.1.10 Corporate Tax Structure
  • 13.1.11 Investments
  • 13.1.12 Major Companies
• 13.2 Western Europe Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.3 Western Europe Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe Blood Plasma Derivatives Market: Country Analysis
• 13.6 UK Market
• 13.7 UK Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.8 UK Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 Germany Market
• 13.11 Germany Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.12 Germany Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 France Market
• 13.15 France Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.16 France Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 Italy Market
• 13.19 Italy Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.20 Italy Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Spain Market
• 13.23 Spain Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.24 Spain Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
  • 14.1.1 Market Overview
  • 14.1.2 Region Information
  • 14.1.3 Market Information
  • 14.1.4 Background Information
  • 14.1.5 Government Initiatives
  • 14.1.6 Regulations
  • 14.1.7 Regulatory Bodies
  • 14.1.8 Major Associations
  • 14.1.9 Taxes Levied
  • 14.1.10 Corporate Tax Structure
  • 14.1.11 Investments
  • 14.1.12 Major Companies
• 14.2 Eastern Europe Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.3 Eastern Europe Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe Blood Plasma Derivatives Market: Country Analysis
• 14.6 Russia Market
• 14.7 Russia Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.8 Russia Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
  • 15.1.1 Market Overview
  • 15.1.2 Region Information
  • 15.1.3 Market Information
  • 15.1.4 Background Information
  • 15.1.5 Government Initiatives
  • 15.1.6 Regulations
  • 15.1.7 Regulatory Bodies
  • 15.1.8 Major Associations
  • 15.1.9 Taxes Levied
  • 15.1.10 Corporate Tax Structure
  • 15.1.11 Investments
  • 15.1.12 Major Companies
• 15.2 North America Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.3 North America Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America Blood Plasma Derivatives Market: Country Analysis
• 15.6 USA Market
• 15.7 Summary
  • 15.7.1 Market Overview
  • 15.7.2 Country Information
  • 15.7.3 Market Information
  • 15.7.4 Background Information
  • 15.7.5 Government Initiatives
  • 15.7.6 Regulations
  • 15.7.7 Regulatory Bodies
  • 15.7.8 Major Associations
  • 15.7.9 Taxes Levied
  • 15.7.10 Corporate Tax Structure
  • 15.7.11 Investments
  • 15.7.12 Major Companies
• 15.8 USA Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.9 USA Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.10 USA Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 Canada Market
• 15.12 Canada Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.13 Canada Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.14 Canada Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
  • 16.1.1 Market Overview
  • 16.1.2 Region Information
  • 16.1.3 Market Information
  • 16.1.4 Background Information
  • 16.1.5 Government Initiatives
  • 16.1.6 Regulations
  • 16.1.7 Regulatory Bodies
  • 16.1.8 Major Associations
  • 16.1.9 Taxes Levied
  • 16.1.10 Corporate Tax Structure
  • 16.1.11 Major Companies
• 16.2 South America Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.3 South America Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America Blood Plasma Derivatives Market: Country Analysis
• 16.6 Brazil Market
• 16.7 Brazil Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.8 Brazil Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
  • 17.1.1 Market Overview
  • 17.1.2 Region Information
  • 17.1.3 Market Information
  • 17.1.4 Background Information
  • 17.1.5 Government Initiatives
  • 17.1.6 Regulations
  • 17.1.7 Regulatory Bodies
  • 17.1.8 Major Associations
  • 17.1.9 Taxes Levied
  • 17.1.10 Corporate Tax Structure
  • 17.1.11 Investments
  • 17.1.12 Major Companies
• 17.2 Middle East Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.3 Middle East Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
  • 18.1.1 Market Overview
  • 18.1.2 Region Information
  • 18.1.3 Market Information
  • 18.1.4 Background Information
  • 18.1.5 Government Initiatives
  • 18.1.6 Regulations
  • 18.1.7 Regulatory Bodies
  • 18.1.8 Major Associations
  • 18.1.9 Taxes Levied
  • 18.1.10 Corporate Tax Structure
  • 18.1.11 Investments
  • 18.1.12 Major Companies
• 18.2 Africa Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.3 Africa Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Company Profiles
• 19.2 CSL Limited
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial Overview
• 19.3 China Biologic Products Holdings Inc.
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Financial Overview
• 19.4 Takeda Pharmaceutical Company Limited
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Performance
• 19.5 Octapharma AG
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview
• 19.6 Bayer AG
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Financial Performance

20 Blood Plasma Derivatives Market Other Major And Innovative Companies

• 20.1 Kedrion S.p.A.
  • 20.1.1 Company Overview
  • 20.1.2 Products And Services
• 20.2 Bio Products Ltd.
  • 20.2.1 Company Overview
  • 20.2.2 Products And Services
• 20.3 Grifols S.A.
  • 20.3.1 Company Overview
  • 20.3.2 Products And Services
• 20.4 LFB S.A.
  • 20.4.1 Company Overview
  • 20.4.2 Products And Services
• 20.5 ADMA Biologics Inc.
  • 20.5.1 Company Overview
  • 20.5.2 Products And Services
• 20.6 GC Biopharma Corp.
  • 20.6.1 Company Overview
  • 20.6.2 Products And Services
• 20.7 Shanghai Raas Blood Products Co. Ltd.
  • 20.7.1 Company Overview
  • 20.7.2 Products And Services
• 20.8 Emergent BioSolutions Inc.
  • 20.8.1 Company Overview
  • 20.8.2 Products And Services
• 20.9 Biotest AG
  • 20.9.1 Company Overview
  • 20.9.2 Products And Services
• 20.10 SK Plasma Co., Ltd.
  • 20.10.1 Company Overview
  • 20.10.2 Products And Services
• 20.11 BioreclamationIVT
  • 20.11.1 Company Overview
  • 20.11.2 Products And Services
• 20.12 Fusion Health Care Pvt. Ltd.
  • 20.12.1 Company Overview
  • 20.12.2 Products And Services
• 20.13 PlasmaGen BioSciences Private Limited
  • 20.13.1 Company Overview
  • 20.13.2 Products And Services
• 20.14 Cambryn Biologics LLC
  • 20.14.1 Company Overview
  • 20.14.2 Products And Services
• 20.15 Sanquin Innovation B.V.
  • 20.15.1 Company Overview
  • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

• 23.1 Pfizer Inc. Acquired Blood Therapeutics Inc.
• 23.2 Grifols S.A. Acquired Biotest AG
• 23.3 Grifols S.A. Acquired 25 Plasma Centers From BPL Plasma Inc.
• 23.4 Permira Acquired Kedrion Biopharma
• 23.5 Kamada Ltd. Acquired FDA-Licensed Plasma Collection Center From Blood and Plasma Research Inc.

24 Opportunities And Strategies

• 24.1 Global Blood Plasma Derivatives Market In 2028 - Countries Offering Most New Opportunities
• 24.2 Global Blood Plasma Derivatives Market In 2028 - Segments Offering Most New Opportunities
• 24.3 Global Blood Plasma Derivatives Market In 2028 - Growth Strategies
  • 24.3.1 Market Trend Based Strategies
  • 24.3.2 Competitor Strategies

25 Blood Plasma Derivatives Market, Conclusions And Recommendations

• 25.1 Conclusions
• 25.2 Recommendations
  • 25.2.1 Product
  • 25.2.2 Place
  • 25.2.3 Price
  • 25.2.4 Promotion
  • 25.2.5 People

26 Appendix

• 26.1 Geographies Covered
• 26.2 Market Data Sources
• 26.3 Research Methodology
• 26.4 Currencies
• 26.5 The Business Research Company
• 26.6 Copyright and Disclaimer